Research graph
References from Strength training intervention with creatine/whey protein supplementation vs placebo on frailty in older adults with cirrhosis (STRIVE): A Randomized Controlled Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Frailty in older adults: a nationally representative profile in the United States
10.1093/gerona/glv133 · 2015 · External reference
Frailty in older adults
10.1056/nejmra2301292 · 2024 · External reference
Quality of life in sarcopenia and frailty
10.1007/s00223-013-9758-y · 2013 · External reference
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
10.1016/s2468-2667(18)30091-4 · 2018 · External reference
Rodríguez-Mañas L. Healthcare cost expenditures associated to frailty and sarcopenia
10.1186/s12877-022-03439-z · 2022 · External reference
Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice
10.1111/ajt.15392 · 2019 · External reference
Multicenter study of age, frailty, and waitlist mortality among liver transplant candidates
10.1097/sla.0000000000003207 · 2020 · External reference
Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases
10.1002/hep.32049 · 2021 · External reference
Frailty and outcomes after liver transplantation
10.1007/s40472-019-0222-4 · 2019 · External reference
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
10.1002/hep.32268 · 2022 · External reference
Association of frailty with health-related quality of life in liver transplant recipients
10.1001/jamasurg.2022.6387 · 2023 · External reference
10.1007/978-3-031-08552-9_50
10.1007/978-3-031-08552-9_50 · External reference
Frailty is associated with increased risk of cirrhosis disease progression and death
10.1002/hep.32157 · 2022 · External reference
impact of exercise on physical frailty in patients with chronic liver disease
10.1111/apt.15491 · 2019 · External reference
Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease
10.14309/ajg.0000000000001376 · 2021 · External reference
Benefits of resistance training in early and late stages of frailty and sarcopenia: a systematic review and meta-analysis of randomized controlled studies
10.3390/jcm10081630 · 2021 · External reference
Branched-chain amino acid supplements for sarcopenia in liver cirrhosis: a systematic review and meta-analysis
10.1016/j.jceh.2024.102417 · 2025 · External reference
Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice?
10.3390/nu12010186 · 2020 · External reference
Interventions to improve physical function and prevent adverse events in cirrhosis
10.1093/gastro/gox042 · 2018 · External reference
Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review
2018 · External reference
Creatine supplementation in the aging population: effects on skeletal muscle, bone and brain
10.1007/s00726-016-2239-7 · 2016 · External reference
Creatine supplementation and aging musculoskeletal health
10.1007/s12020-013-0070-4 · 2014 · External reference
Resistance training and co-supplementation with creatine and protein in older subjects with frailty
2016 · External reference
The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men
10.1007/s12603-009-0124-8 · 2010 · External reference
Creatine supplementation: an update
10.1249/jsr.0000000000000863 · 2021 · External reference
The effects of creatine and whey protein supplementation on body composition in men aged 48 to 72 years during resistance training
10.1007/bf02982622 · 2008 · External reference
The additive effects of creatine supplementation and exercise training in an aging population: a systematic review of randomized controlled trials
10.1519/jpt.0000000000000222 · 2020 · External reference
Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial
10.1186/s12876-023-02789-1 · 2023 · External reference
Validation of the PAR-Q + and ePARmed-X+
2011 · External reference
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease
10.1097/hep.0000000000000480 · 2023 · External reference
The Godin-Shephard leisure-time physical activity questionnaire
2011 · External reference
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)
10.1016/0002-9149(89)90496-7 · 1989 · External reference
Unresolved reference
2024 · External reference
Comparison of the diet ID platform to the automated self-administered 24-hour (ASA24) dietary assessment tool for assessment of dietary intake
10.1080/07315724.2021.1887775 · 2022 · External reference
The automated self-administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians and educators from the National Cancer Institute
10.1016/j.jand.2012.04.016 · 2012 · External reference
Creatine o'clock: does timing of ingestion really influence muscle mass and performance? Frontiers in sports and active living
2022 · External reference
Creatine supplementation to improve Sarcopenia in chronic liver disease: facts and perspectives
10.3390/nu15040863 · 2023 · External reference
Development of a novel frailty index to predict mortality in patients with end-stage liver disease
10.1002/hep.29219 · 2017 · External reference
Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease
10.14309/ajg.0000000000001376 · 2021 · External reference
The range and reproducibility of the liver frailty index
10.1002/lt.25449 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
An open label feasibility study of a nutrition and exercise app-based solution in cirrhosis
10.3138/canlivj-2023-0011 · 2024 · External reference
Heal-me PiONEer (personalized online nutrition and exercise): an RCT assessing 2 levels of app-based programming in individuals with chronic disease
10.1016/j.cct.2022.106791 · 2022 · External reference
Association of frailty with health-related quality of life in liver transplant recipients
10.1001/jamasurg.2022.6387 · ExternalCitation · doi-reference
Development of a novel frailty index to predict mortality in patients with end-stage liver disease
10.1002/hep.29219 · ExternalCitation · doi-reference
Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases
10.1002/hep.32049 · ExternalCitation · doi-reference
Frailty is associated with increased risk of cirrhosis disease progression and death
10.1002/hep.32157 · ExternalCitation · doi-reference
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
10.1002/hep.32268 · ExternalCitation · doi-reference
The range and reproducibility of the liver frailty index
10.1002/lt.25449 · ExternalCitation · doi-reference
10.1007/978-3-031-08552-9_50
10.1007/978-3-031-08552-9_50 · ExternalCitation · doi-reference
The effects of creatine and whey protein supplementation on body composition in men aged 48 to 72 years during resistance training
10.1007/bf02982622 · ExternalCitation · doi-reference
Quality of life in sarcopenia and frailty
10.1007/s00223-013-9758-y · ExternalCitation · doi-reference
Creatine supplementation in the aging population: effects on skeletal muscle, bone and brain
10.1007/s00726-016-2239-7 · ExternalCitation · doi-reference
Creatine supplementation and aging musculoskeletal health
10.1007/s12020-013-0070-4 · ExternalCitation · doi-reference
The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men
10.1007/s12603-009-0124-8 · ExternalCitation · doi-reference
Frailty and outcomes after liver transplantation
10.1007/s40472-019-0222-4 · ExternalCitation · doi-reference
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)
10.1016/0002-9149(89)90496-7 · ExternalCitation · doi-reference
Heal-me PiONEer (personalized online nutrition and exercise): an RCT assessing 2 levels of app-based programming in individuals with chronic disease
10.1016/j.cct.2022.106791 · ExternalCitation · doi-reference
The automated self-administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians and educators from the National Cancer Institute
10.1016/j.jand.2012.04.016 · ExternalCitation · doi-reference
Branched-chain amino acid supplements for sarcopenia in liver cirrhosis: a systematic review and meta-analysis
10.1016/j.jceh.2024.102417 · ExternalCitation · doi-reference
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
10.1016/s2468-2667(18)30091-4 · ExternalCitation · doi-reference
Frailty in older adults
10.1056/nejmra2301292 · ExternalCitation · doi-reference
Comparison of the diet ID platform to the automated self-administered 24-hour (ASA24) dietary assessment tool for assessment of dietary intake
10.1080/07315724.2021.1887775 · ExternalCitation · doi-reference
Interventions to improve physical function and prevent adverse events in cirrhosis
10.1093/gastro/gox042 · ExternalCitation · doi-reference
Frailty in older adults: a nationally representative profile in the United States
10.1093/gerona/glv133 · ExternalCitation · doi-reference
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease
10.1097/hep.0000000000000480 · ExternalCitation · doi-reference
Multicenter study of age, frailty, and waitlist mortality among liver transplant candidates
10.1097/sla.0000000000003207 · ExternalCitation · doi-reference
Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice
10.1111/ajt.15392 · ExternalCitation · doi-reference
impact of exercise on physical frailty in patients with chronic liver disease
10.1111/apt.15491 · ExternalCitation · doi-reference
Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial
10.1186/s12876-023-02789-1 · ExternalCitation · doi-reference
Rodríguez-Mañas L. Healthcare cost expenditures associated to frailty and sarcopenia
10.1186/s12877-022-03439-z · ExternalCitation · doi-reference
Creatine supplementation: an update
10.1249/jsr.0000000000000863 · ExternalCitation · doi-reference
Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease
10.14309/ajg.0000000000001376 · ExternalCitation · doi-reference
The additive effects of creatine supplementation and exercise training in an aging population: a systematic review of randomized controlled trials
10.1519/jpt.0000000000000222 · ExternalCitation · doi-reference
An open label feasibility study of a nutrition and exercise app-based solution in cirrhosis
10.3138/canlivj-2023-0011 · ExternalCitation · doi-reference
Benefits of resistance training in early and late stages of frailty and sarcopenia: a systematic review and meta-analysis of randomized controlled studies
10.3390/jcm10081630 · ExternalCitation · doi-reference
Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice?
10.3390/nu12010186 · ExternalCitation · doi-reference
Creatine supplementation to improve Sarcopenia in chronic liver disease: facts and perspectives
10.3390/nu15040863 · ExternalCitation · doi-reference
